ONGLYZA 2.5 MG 14 TABLETS | Saxagliptin for Type 2 Diabetes
ONGLYZA 2.5 MG 14 TABLETS contain Saxagliptin 2.5 mg, a prescription DPP-4 inhibitor used with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
GLYZA 2.5 MG 14 TABLETS
ONGLYZA 2.5 MG 14 TABLETS (Saxagliptin 2.5 mg): Comprehensive Guide and Benefits
Introduction to ONGLYZA 2.5 MG 14 TABLETS
A DPP-4 Inhibitor for Type 2 Diabetes Management
ONGLYZA 2.5 MG 14 TABLETS are a prescription-only medicine containing Saxagliptin 2.5 mg, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor. It is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It may be prescribed alone when metformin is not suitable or in combination with other antidiabetic medicines, including insulin.
Key Benefits of ONGLYZA 2.5 MG 14 TABLETS
Helps lower blood glucose levels in adults with type 2 diabetes.
Improves long-term glycemic control (HbA1c).
Can be used alone or in combination with other diabetes medicines.
Convenient once-daily oral dosing.
Low risk of hypoglycemia when used alone.
How ONGLYZA 2.5 MG Works
Saxagliptin inhibits the DPP-4 enzyme, increasing the levels of incretin hormones (GLP-1 and GIP). These hormones stimulate insulin release when blood sugar is high and reduce glucagon production, helping lower blood glucose after meals and between meals.
Usage Instructions
Take exactly as prescribed by your healthcare provider.
Usually taken once daily, with or without food.
Swallow the tablet whole with water.
Take it at the same time every day.
Continue your recommended diabetic diet and exercise plan.
Do not stop treatment without consulting your doctor.
Medicinal Advantages
Effective oral therapy for type 2 diabetes.
Helps maintain stable blood glucose levels.
Suitable for combination therapy with metformin, insulin, sulfonylureas, and other antidiabetic medicines.
Once-daily dosing improves treatment adherence.
Generally well tolerated when used as directed.
NOTE: ONGLYZA is intended for type 2 diabetes mellitus only. It is not indicated for type 1 diabetes or diabetic ketoacidosis.
Off-Label Uses
Saxagliptin should generally be used only for its approved indication in type 2 diabetes unless otherwise directed by a healthcare professional.
Expert Advice
Monitor your blood glucose regularly.
Maintain a healthy diet and regular exercise.
Inform your doctor if you develop severe abdominal pain, persistent nausea, or vomiting.
Seek medical advice if you experience symptoms of heart failure such as shortness of breath, swelling of the feet, or unusual fatigue.
Attend regular follow-up appointments to monitor kidney function and diabetes control.
Precautions
Pregnancy & Breastfeeding
Consult your healthcare provider before using ONGLYZA during pregnancy or breastfeeding. Treatment should only be used if the potential benefits outweigh the risks.
Kidney Function
The 2.5 mg strength is commonly recommended for patients with moderate or severe kidney impairment (eGFR below 45 mL/min/1.73 m²). Kidney function should be assessed before starting treatment and monitored periodically.
Drug Interactions
Inform your healthcare provider if you are taking:
Insulin or sulfonylureas.
Strong CYP3A4/5 inhibitors (e.g., ketoconazole).
Other diabetes medicines.
Dose adjustments may be necessary to reduce the risk of hypoglycemia or interactions.
Existing Medical Conditions
Tell your healthcare provider if you have:
Kidney disease.
Heart failure.
History of pancreatitis.
Liver disease.
Type 1 diabetes or diabetic ketoacidosis.
Storage Instructions
Store below 30°C.
Keep in the original blister pack.
Protect from moisture and excessive heat.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is ONGLYZA 2.5 MG used for?
A: It is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Q: What is the active ingredient?
A: Each tablet contains Saxagliptin 2.5 mg.
Q: Who is usually prescribed the 2.5 mg strength?
A: The 2.5 mg dose is commonly prescribed for patients with moderate or severe kidney impairment or in certain situations where a lower dose is appropriate, as determined by a healthcare provider.
Q: What are the common side effects?
A: Common side effects include headache, upper respiratory tract infection, urinary tract infection, sore throat, and nasopharyngitis.
Q: Can ONGLYZA cause low blood sugar?
A: When used alone, the risk is generally low. However, the risk increases when combined with insulin or sulfonylureas.
Q: Is ONGLYZA suitable for type 1 diabetes?
A: No. ONGLYZA is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
Q: Is ONGLYZA available without a prescription?
A: No. ONGLYZA 2.5 MG is a prescription-only medicine and should be used only under the supervision of a qualified healthcare professional.
Product Tags
ONGLYZA 2.5 MG 14 TABLETS, Saxagliptin 2.5 mg, Saxagliptin Tablet, DPP-4 Inhibitor, Type 2 Diabetes Medicine, Blood Sugar Control, Diabetes Management, Oral Antidiabetic Tablet, HbA1c Reduction, Prescription Diabetes Medicine, Diabetes Care, Once Daily Diabetes Tablet, Glycemic Control, Adult Diabetes Therapy, ONGLYZA Tablet, Saxagliptin 2.5 mg Tablet, Kidney Impairment Dose, Prescription Antidiabetic Medicine, DPP-4 Diabetes Drug, Type 2 Diabetes Treatment
